697 related articles for article (PubMed ID: 3468100)
21. In vitro activity of CI-934 compared with ciprofloxacin, enoxacin, norfloxacin, and vancomycin.
Floyd-Reising SA; Kelley SG; Hindler JA; Young LS
Diagn Microbiol Infect Dis; 1987 Apr; 6(4):301-6. PubMed ID: 3472704
[TBL] [Abstract][Full Text] [Related]
22. The in-vitro activity of temafloxacin compared with other antimicrobial agents.
King A; Bethune L; Phillips I
J Antimicrob Chemother; 1991 Jun; 27(6):769-79. PubMed ID: 1657855
[TBL] [Abstract][Full Text] [Related]
23. The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.
O'Hare MD; Felmingham D; Ridgway GL; Grüneberg RN
Drugs Exp Clin Res; 1985; 11(4):253-7. PubMed ID: 2941257
[TBL] [Abstract][Full Text] [Related]
24. [Comparative bacteriologic activity of norfloxacin, ofloxacin and pefloxacin against 320 Gram-negative bacilli resistant and non-resistant to nalidixic acid and cephalosporins].
Croize J; Le Noc P; Bryskier A; Robert J
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):564-8. PubMed ID: 3937128
[TBL] [Abstract][Full Text] [Related]
25. Comparative in vitro activities of ciprofloxacin, enoxacin, norfloxacin, ofloxacin and pefloxacin against Bacteroides fragilis and Clostridium difficile.
Edlund C; Nord CE
Scand J Infect Dis; 1986; 18(2):149-51. PubMed ID: 2939556
[TBL] [Abstract][Full Text] [Related]
26. The in-vitro activity of tosufloxacin, a new fluorinated quinolone, compared with that of ciprofloxacin and temafloxacin.
King A; Bethune L; Phillips I
J Antimicrob Chemother; 1991 Nov; 28(5):719-25. PubMed ID: 1663930
[TBL] [Abstract][Full Text] [Related]
27. The comparative activity of twelve 4-quinolone antimicrobials against Haemophilus influenzae and Streptococcus pneumoniae.
Ridgway GL; O'Hare MD; Felmingham D; Grüneberg RN
Drugs Exp Clin Res; 1985; 11(4):259-62. PubMed ID: 2941258
[TBL] [Abstract][Full Text] [Related]
28. The in-vitro activity of ciprofloxacin compared with that of norfloxacin and nalidixic acid.
King A; Shannon K; Phillips I
J Antimicrob Chemother; 1984 Apr; 13(4):325-31. PubMed ID: 6233249
[TBL] [Abstract][Full Text] [Related]
29. Comparative in-vitro activity of Ro 23-6240, a new trifluorinated quinolone.
Verbist L
J Antimicrob Chemother; 1987 Sep; 20(3):363-72. PubMed ID: 3119552
[TBL] [Abstract][Full Text] [Related]
30. [In vitro antibacterial activity of 2 new quinolones: A 56619 (difloxacin) and A 56620. Comparison with pefloxacin, ofloxacin and ciprofloxacin].
Soussy CJ; Deforges L; Le Van Thoi J; Duval J
Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):759-67. PubMed ID: 3309811
[TBL] [Abstract][Full Text] [Related]
31. In vitro activity of RO 23-6240 (AM-833): a new fluoroquinolone.
Fass RJ; Helsel VL
Diagn Microbiol Infect Dis; 1987 Apr; 6(4):293-9. PubMed ID: 3107872
[TBL] [Abstract][Full Text] [Related]
32. [Comparative in vitro study of the activity of 5 quinolones against Acinetobacter calcoaceticus].
Joly-Guillou ML; Bergogne-Berezin E
Pathol Biol (Paris); 1985 May; 33(5):416-20. PubMed ID: 3162142
[TBL] [Abstract][Full Text] [Related]
33. A laboratory assessment of ciprofloxacin and comparable antimicrobial agents.
Shrire L; Saunders J; Traynor R; Koornhof HJ
Eur J Clin Microbiol; 1984 Aug; 3(4):328-32. PubMed ID: 6237900
[TBL] [Abstract][Full Text] [Related]
34. The in-vitro activity of EN 272, a quinolone-7-carboxylic acid, in comparison with other quinolones.
Neu HC
J Antimicrob Chemother; 1985 Jul; 16(1):43-8. PubMed ID: 3862659
[TBL] [Abstract][Full Text] [Related]
35. In-vitro activity of enoxacin against aminoglycoside-resistant gram-negative bacilli and other clinical isolates.
Duncan IB; Skulnick M; Marshall PW
J Antimicrob Chemother; 1984 Sep; 14 Suppl C():1-6. PubMed ID: 6438046
[TBL] [Abstract][Full Text] [Related]
36. Comparative in vitro activity of amifloxacin and five other fluoroquinolone antimicrobial agents and preliminary criteria for the disk susceptibility test.
Barry AL; Jones RN
Eur J Clin Microbiol; 1987 Apr; 6(2):179-82. PubMed ID: 3474145
[TBL] [Abstract][Full Text] [Related]
37. In vitro antimicrobial activity of sparfloxacin (AT-4140, CI-978, PD 131501) compared with numerous other quinolone compounds.
Jones RN; Barrett MS; Erwin ME; Briggs BM; Johnson DM
Diagn Microbiol Infect Dis; 1991; 14(4):319-30. PubMed ID: 1909615
[TBL] [Abstract][Full Text] [Related]
38. Activity of pefloxacin and thirteen other antimicrobial agents in vitro against isolates from hospital and genitourinary infections.
Jones BM; Geary I; Lee ME; Duerden BI
J Antimicrob Chemother; 1986 Jun; 17(6):739-46. PubMed ID: 3460983
[TBL] [Abstract][Full Text] [Related]
39. In vitro activity of the newer quinolones compared with the classic ones and tobramycin.
Boquet Jiménez E; Dalet Escribá F; Caballé L
Infection; 1985; 13(4):193-6. PubMed ID: 2931382
[TBL] [Abstract][Full Text] [Related]
40. In-vitro activity of enoxacin, ofloxacin, norfloxacin and nalidixic acid.
Bauernfeind A; Ullmann U
J Antimicrob Chemother; 1984 Sep; 14 Suppl C():33-8. PubMed ID: 6238931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]